These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9300596)

  • 1. Role of cerebral dopamine and noradrenaline in the morphine-induced locomotor sensitisation in mice.
    Airio J; Ahtee L
    Pharmacol Biochem Behav; 1997 Oct; 58(2):379-86. PubMed ID: 9300596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment.
    Airio J; Ahtee L
    Br J Pharmacol; 1999 Apr; 126(7):1609-19. PubMed ID: 10323593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional differences in cerebral noradrenaline turnover in mice withdrawn from repeated morphine treatment and tolerance to the effects of acute morphine.
    Airio J; Attila M; Ahtee L
    Pharmacol Toxicol; 1995 Sep; 77(3):196-203. PubMed ID: 8884883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal from repeated morphine sensitizes mice to the striatal dopamine release enhancing effect of acute morphine.
    Airio J; Attila M; Leikola-Pelho T; Ahtee L
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Nov; 350(5):548-54. PubMed ID: 7870194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of morphine on locomotor activity and striatal monoamine metabolism in nicotine-withdrawn mice.
    Vihavainen T; Mijatovic J; Piepponen TP; Tuominen RK; Ahtee L
    Behav Brain Res; 2006 Oct; 173(1):85-93. PubMed ID: 16846651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the effects of morphine on the alpha-methyl-p-tyrosine-induced depletion of dopamine and noradrenaline in various areas of the mouse brain.
    Martti L; Attila J; Etemadzadeh E; Ahtee L
    Pharmacol Toxicol; 1987 Jul; 61(1):26-32. PubMed ID: 3628178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days' morphine treatment.
    Attila LM; Ahtee L
    Med Biol; 1983; 61(5):249-257. PubMed ID: 6686987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral catecholamine depletion in mice withdrawn from repeated morphine treatment and development of tolerance to the enhancing effect of morphine on noradrenaline depletion.
    Etemadzadeh E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):749-55. PubMed ID: 8355206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats.
    Wei XL; Su RB; Wu N; Lu XQ; Zheng JQ; Li J
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):790-9. PubMed ID: 17604969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of morphine-induced changes in brain monoamine metabolism after chronic naltrexone treatment.
    Ahtee L; Attila LM; Carlson KR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):803-8. PubMed ID: 2243351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral dopamine and noradrenaline in mice withdrawn from repeated morphine treatment and development of tolerance to a test dose of morphine.
    Etemadzadeh E
    Gen Pharmacol; 1994 Jul; 25(4):623-9. PubMed ID: 7958720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats.
    Attila LM; Ahtee L
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):201-7. PubMed ID: 6541759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered.
    Airavaara M; Mijatovic J; Vihavainen T; Piepponen TP; Saarma M; Ahtee L
    Synapse; 2006 May; 59(6):321-9. PubMed ID: 16437537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceleration of cerebral noradrenaline turnover after morphine withdrawal and its retardation by acute morphine administration in rats.
    Attila LM; Ahtee L
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):193-200. PubMed ID: 6541758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamine utilization in distinct mouse brain nuclei during acute morphine treatment, morphine tolerance and withdrawal syndrome.
    Kovács GL; Acsai L; Tihanyi A; Telegdy G
    Eur J Pharmacol; 1983 Sep; 93(3-4):149-58. PubMed ID: 6685650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
    Fuertes G; Laorden ML; Milanés MV
    Neuroendocrinology; 2000 Jan; 71(1):60-7. PubMed ID: 10644900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in hypothalamic paraventricular nucleus catecholaminergic activity after acute and chronic morphine administration.
    Fuertes G; Milanés MV; Rodríguez-Gago M; Marín MT; Laorden ML
    Eur J Pharmacol; 2000 Jan; 388(1):49-56. PubMed ID: 10657546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of opioid mu1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission.
    Piepponen TP; Honkanen A; Kivastik T; Zharkovsky A; Turtia A; Mikkola JA; Ahtee L
    Pharmacol Biochem Behav; 1999 Jun; 63(2):245-52. PubMed ID: 10371653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine-stimulated metabolism of striatal and limbic dopamine is dissimilarly sensitized in rats upon withdrawal from chronic morphine treatment.
    Honkanen A; Piepponen TP; Ahtee L
    Neurosci Lett; 1994 Oct; 180(2):119-22. PubMed ID: 7700562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of repeated morphine treatment on metabolism of cerebral dopamine and serotonin in alcohol-preferring AA and alcohol-avoiding ANA rats.
    Mikkola JA; Honkanen A; Piepponen TP; Kiianmaa K; Ahtee L
    Alcohol Alcohol; 2001; 36(4):286-91. PubMed ID: 11468126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.